4BM-32453-70679
3 vaccinations
1 coded response
26 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 605 / IL
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Moderna
-
2021-03-14
Registered in v-safe
- 2021-03-14
- 2021-03-17
- 2021-03-22
- 2021-03-29
-
2021-04-05
Dose 2 — Moderna
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety — Feeling: GoodFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-10-04
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-09
- 2021-12-17
- 2022-02-03
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-05 | Moderna | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Anxiety | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release